Limits...
Bone marrow-derived mesenchymal stem cells differentiate into nerve-like cells in vitro after transfection with brain-derived neurotrophic factor gene.

Liu Q, Cheng G, Wang Z, Zhan S, Xiong B, Zhao X - In Vitro Cell. Dev. Biol. Anim. (2015)

Bottom Line: Immunocytochemistry and real-time reverse transcription polymerase chain reaction analysis showed that non-induced BDNF-BMSCs maintained a higher proliferative capacity and expressed higher amounts of brain-derived neurotrophic factor, nestin, neuron-specific enolase, and glial fibrillary acid protein than non-transfected bone marrow-derived mesenchymal stem cells.An additional increase was observed in the induced BDNF-BMSCs compared to the non-induced BDNF-BMSCs.Our data demonstrate that bone marrow-derived mesenchymal stem cells transfected with the BDNF gene can differentiate into nerve-like cells in vitro, which may enable the generation of sufficient quantities of nerve-like cells for treatment of neuronal diseases.

View Article: PubMed Central - PubMed

Affiliation: Department of Otolaryngology, Zhuhai Hospital of Medical College of Jinan University, Zhuhai, 519000, People's Republic of China.

ABSTRACT
Bone marrow-derived mesenchymal stem cells can differentiate into a variety of adult cells. Brain-derived neurotrophic factor (BDNF) is briefly active during differentiation and induces mesenchymal stem cells to differentiate into nerve cells. In this study, we cloned human BDNF to generate a recombinant pcDNA3.1(-)-BDNF vector and transfected the vector into bone marrow-derived mesenchymal stem cells. We selected these cells with Geneticin-418 to obtain BDNF-BMSCs, which were induced with retinoic acid to obtain induced BDNF-BMSCs. The transfected cells displayed the typical morphology and surface antigen profile of fibroblasts and were observed to express clusters of differentiation 29, 44, and 90 (observed in matrix and stromal cells), but not clusters of differentiation 31, 34, and 45 (observed in red blood cells and endothelial cells), via flow cytometry. Enzyme-linked immunosorbent assays showed that transfected bone marrow-derived mesenchymal stem cells secreted more BDNF than non-transfected bone marrow-derived mesenchymal stem cells. Immunocytochemistry and real-time reverse transcription polymerase chain reaction analysis showed that non-induced BDNF-BMSCs maintained a higher proliferative capacity and expressed higher amounts of brain-derived neurotrophic factor, nestin, neuron-specific enolase, and glial fibrillary acid protein than non-transfected bone marrow-derived mesenchymal stem cells. An additional increase was observed in the induced BDNF-BMSCs compared to the non-induced BDNF-BMSCs. This expression profile is characteristic of neurocytes. Our data demonstrate that bone marrow-derived mesenchymal stem cells transfected with the BDNF gene can differentiate into nerve-like cells in vitro, which may enable the generation of sufficient quantities of nerve-like cells for treatment of neuronal diseases.

Show MeSH
Flow cytometric analysis of third-passage BMSCs. (A–C) BMSCs were positive for CD29, CD44, and CD90 staining. (D–E) BMSCs were negative for CD34, CD45, and CD31 staining.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4368845&req=5

Fig2: Flow cytometric analysis of third-passage BMSCs. (A–C) BMSCs were positive for CD29, CD44, and CD90 staining. (D–E) BMSCs were negative for CD34, CD45, and CD31 staining.

Mentions: Flow cytometric analysis demonstrated that BMSCs at passage 3 expressed CD29, CD44, and CD90 (biomarkers of BMSCs) but not CD31, CD34, and CD45 (Fig. 2), indicating that the BMSCs were of high purity.Figure 2


Bone marrow-derived mesenchymal stem cells differentiate into nerve-like cells in vitro after transfection with brain-derived neurotrophic factor gene.

Liu Q, Cheng G, Wang Z, Zhan S, Xiong B, Zhao X - In Vitro Cell. Dev. Biol. Anim. (2015)

Flow cytometric analysis of third-passage BMSCs. (A–C) BMSCs were positive for CD29, CD44, and CD90 staining. (D–E) BMSCs were negative for CD34, CD45, and CD31 staining.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4368845&req=5

Fig2: Flow cytometric analysis of third-passage BMSCs. (A–C) BMSCs were positive for CD29, CD44, and CD90 staining. (D–E) BMSCs were negative for CD34, CD45, and CD31 staining.
Mentions: Flow cytometric analysis demonstrated that BMSCs at passage 3 expressed CD29, CD44, and CD90 (biomarkers of BMSCs) but not CD31, CD34, and CD45 (Fig. 2), indicating that the BMSCs were of high purity.Figure 2

Bottom Line: Immunocytochemistry and real-time reverse transcription polymerase chain reaction analysis showed that non-induced BDNF-BMSCs maintained a higher proliferative capacity and expressed higher amounts of brain-derived neurotrophic factor, nestin, neuron-specific enolase, and glial fibrillary acid protein than non-transfected bone marrow-derived mesenchymal stem cells.An additional increase was observed in the induced BDNF-BMSCs compared to the non-induced BDNF-BMSCs.Our data demonstrate that bone marrow-derived mesenchymal stem cells transfected with the BDNF gene can differentiate into nerve-like cells in vitro, which may enable the generation of sufficient quantities of nerve-like cells for treatment of neuronal diseases.

View Article: PubMed Central - PubMed

Affiliation: Department of Otolaryngology, Zhuhai Hospital of Medical College of Jinan University, Zhuhai, 519000, People's Republic of China.

ABSTRACT
Bone marrow-derived mesenchymal stem cells can differentiate into a variety of adult cells. Brain-derived neurotrophic factor (BDNF) is briefly active during differentiation and induces mesenchymal stem cells to differentiate into nerve cells. In this study, we cloned human BDNF to generate a recombinant pcDNA3.1(-)-BDNF vector and transfected the vector into bone marrow-derived mesenchymal stem cells. We selected these cells with Geneticin-418 to obtain BDNF-BMSCs, which were induced with retinoic acid to obtain induced BDNF-BMSCs. The transfected cells displayed the typical morphology and surface antigen profile of fibroblasts and were observed to express clusters of differentiation 29, 44, and 90 (observed in matrix and stromal cells), but not clusters of differentiation 31, 34, and 45 (observed in red blood cells and endothelial cells), via flow cytometry. Enzyme-linked immunosorbent assays showed that transfected bone marrow-derived mesenchymal stem cells secreted more BDNF than non-transfected bone marrow-derived mesenchymal stem cells. Immunocytochemistry and real-time reverse transcription polymerase chain reaction analysis showed that non-induced BDNF-BMSCs maintained a higher proliferative capacity and expressed higher amounts of brain-derived neurotrophic factor, nestin, neuron-specific enolase, and glial fibrillary acid protein than non-transfected bone marrow-derived mesenchymal stem cells. An additional increase was observed in the induced BDNF-BMSCs compared to the non-induced BDNF-BMSCs. This expression profile is characteristic of neurocytes. Our data demonstrate that bone marrow-derived mesenchymal stem cells transfected with the BDNF gene can differentiate into nerve-like cells in vitro, which may enable the generation of sufficient quantities of nerve-like cells for treatment of neuronal diseases.

Show MeSH